Mucopolysaccharidosis Market Evolution and the Future of Rare...

added blog Health

2026-05-08 18:44:21 - Translate

Mucopolysaccharidosis Market Evolution and the Future of Rare Disease Treatment

Mucopolysaccharidosis Market and the Expanding Therapeutic Landscape Mucopolysaccharidosis (MPS) comprises a group of inherited metabolic disorders resulting from deficiencies in lysosomal enzymes that are responsible for degrading glycosaminoglycans. The accumulation of these substances progressively damages organs and tissues, leading to complications that affect the skeletal,...

0 Comments 0 Shares 691 Views 0 Reviews